tradingkey.logo

Lifecore Biomedical Inc

LFCR
8.170USD
+0.130+1.62%
收盤 12/22, 16:00美東報價延遲15分鐘
306.10M總市值
虧損本益比TTM

Lifecore Biomedical Inc

8.170
+0.130+1.62%

關於 Lifecore Biomedical Inc 公司

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Inc簡介

公司代碼LFCR
公司名稱Lifecore Biomedical Inc
上市日期Feb 15, 1996
CEOJosephs (Paul)
員工數量406
證券類型Ordinary Share
年結日Feb 15
公司地址3515 Lyman Boulevard
城市CHASKA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編55318
電話19523684300
網址https://www.lifecore.com/
公司代碼LFCR
上市日期Feb 15, 1996
CEOJosephs (Paul)

Lifecore Biomedical Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ms. Stephanie Diaz
Ms. Stephanie Diaz
Investor Relations
Investor Relations
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Matthew Edward Korenberg
Mr. Matthew Edward Korenberg
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%

收入明細

單位: USD更新時間: 3月4日 週二
單位: USD更新時間: 3月4日 週二
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
地區USD
名稱
營收
佔比
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
其他
1.50M
5.43%
業務
地區
業務USD
名稱
營收
佔比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.91%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
其他
54.83%
持股股東
持股股東
佔比
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.91%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
其他
54.83%
股東類型
持股股東
佔比
Hedge Fund
30.51%
Investment Advisor
23.96%
Investment Advisor/Hedge Fund
18.29%
Research Firm
1.93%
Individual Investor
1.85%
Private Equity
0.17%
Bank and Trust
0.11%
Pension Fund
0.05%
Insurance Company
0.03%
其他
23.09%

機構持股

更新時間: 10月5日 週日
更新時間: 10月5日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
203
28.27M
75.45%
-763.44K
2025Q2
212
27.35M
73.90%
-2.82M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Wynnefield Capital, Inc.
4.70M
9.16%
--
--
Jun 30, 2025
Legion Partners Asset Management, LLC
4.43M
8.63%
--
--
Jun 30, 2025
Greenhaven Road Investment Management, L.P.
3.69M
7.19%
+78.69K
+2.18%
Jun 30, 2025
325 Capital LLC
2.16M
4.21%
+1.00
+0.00%
Sep 02, 2025
Laughing Water Capital, LP
1.90M
3.7%
--
--
Sep 02, 2025
David Capital Partners, LLC
1.80M
3.51%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.72M
3.35%
+90.16K
+5.52%
Jun 30, 2025
The Vanguard Group, Inc.
1.61M
3.13%
+63.30K
+4.09%
Jun 30, 2025
Geode Capital Management, L.L.C.
775.49K
1.51%
+25.00K
+3.33%
Jun 30, 2025
GrizzlyRock Capital, LLC
734.53K
1.43%
+734.53K
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Motley Fool Next Index ETF
0.01%
ProShares Hedge Replication ETF
0.01%
查看更多
iShares Micro-Cap ETF
佔比0.04%
WisdomTree US SmallCap Fund
佔比0.03%
Global X Russell 2000 ETF
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
Motley Fool Next Index ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Lifecore Biomedical Inc的前五大股東是誰?

Lifecore Biomedical Inc的前五大股東如下:
Wynnefield Capital, Inc.
持有股份:4.70M
佔總股份比例:9.16%。
Legion Partners Asset Management, LLC
持有股份:4.43M
佔總股份比例:8.63%。
Greenhaven Road Investment Management, L.P.
持有股份:3.69M
佔總股份比例:7.19%。
325 Capital LLC
持有股份:2.16M
佔總股份比例:4.21%。
Laughing Water Capital, LP
持有股份:1.90M
佔總股份比例:3.70%。

Lifecore Biomedical Inc的前三大股東類型是什麼?

Lifecore Biomedical Inc 的前三大股東類型分別是:
Wynnefield Capital, Inc.
Legion Partners Asset Management, LLC
Greenhaven Road Investment Management, L.P.

有多少機構持有Lifecore Biomedical Inc(LFCR)的股份?

截至2025Q3,共有203家機構持有Lifecore Biomedical Inc的股份,合計持有的股份價值約為28.27M,占公司總股份的75.45% 。與2025Q2相比,機構持股有所增加,增幅為1.56%。

哪個業務部門對Lifecore Biomedical Inc的收入貢獻最大?

在FY2023Q3,Contract development and manufacturing organization ("CDMO")業務部門對Lifecore Biomedical Inc的收入貢獻最大,創收17.81M,占總收入的64.53% 。
KeyAI